Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis

Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis

Patients with hepatitis C virus (HCV) genotype 3 (GT3) infection are resistant to direct-acting antiviral (DAA) treatments. This study aimed to analyze the effectiveness of sofosbuvir (SOF) + daclatasvir (DCV) ± ribavirin (RBV); SOF + velpatasvir (VEL) ± RBV; SOF + VEL + voxilaprevir (VOX); and glec...

Full description

Bibliographic Details
Main Authors: Liwei Zhuang, Junnan Li, Yu Zhang, Shibo Ji, Yue Li, Yingying Zhao, Ben Li, Wei Li, Min Quan, Ying Duan, Hong Zhao, Danying Cheng, Xiaomei Wang, Weini Ou, Huichun Xing
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Annals of Hepatology
Subjects:
Direct-acting antiviral
Effectiveness
Real-world
Genotype 3 HCV
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268120301836

Internet

http://www.sciencedirect.com/science/article/pii/S1665268120301836

Similar Items